Your browser doesn't support javascript.
loading
Global Asthma Network Phase I study in Mexico: prevalence of asthma symptoms, risk factors and altitude associations-a cross-sectional study.
Del-Río-Navarro, Blanca Estela; Berber, Arturo; Reyes-Noriega, Nayely; Navarrete-Rodríguez, Elsy Maureen; García-Almaraz, Roberto; Ellwood, Philippa; Garcia-Marcos, Luis; Saucedo-Ramírez, Omar Josué; Mérida-Palacio, Valente Juan; Ramos-García, Beatriz Del Carmen; Escalante-Domínguez, Alberto José; Linares-Zapién, Francisco Javier; Moreno-Gardea, Héctor Leonardo; Ochoa-López, Georgina; Hernández-Mondragón, Luis Octavio; Lozano-Sáenz, José Santos; Sacre-Hazouri, José Antonio; Juan-Pineda, Ángeles; Sánchez-Coronel, Ma Guadalupe; Rodríguez-Pérez, Noel; Ambriz-Moreno, María de Jesús.
Afiliação
  • Del-Río-Navarro BE; Allergy and Immunology, Hospital Infantil de México Federico Gomez, Mexico City, Mexico.
  • Berber A; Allergy and Immunology, Hospital Infantil de México Federico Gomez, Mexico City, Mexico.
  • Reyes-Noriega N; Allergy and Immunology, Hospital Infantil de México Federico Gomez, Mexico City, Mexico naye.rey.nor@gmail.com.
  • Navarrete-Rodríguez EM; Allergy and Immunology, Hospital Infantil de México Federico Gomez, Mexico City, Mexico.
  • García-Almaraz R; Allergy and Immunology, Hospital Infantil de Tamaulipas, Ciudad Victoria, Mexico.
  • Ellwood P; Paediatrics: Child and Youth Health, The University of Auckland, Auckland, New Zealand.
  • Garcia-Marcos L; Paediatric Allergy and Pulmonology Units 'Virgen de la Arrixaca' University Children's Hospital, University of Murcia, Universidad de Murcia, Murcia, Spain.
  • Saucedo-Ramírez OJ; Allergy and Immunology, Hospital Infantil de México Federico Gomez, Mexico City, Mexico.
  • Mérida-Palacio VJ; Allergy and Immunology, Clínica de Asma-Alergia, Mexicali, Mexico.
  • Ramos-García BDC; Allergy and Immunology, Instituto Mexicano del Seguro Social, San Luis Potosí, San Luis Potosí, Mexico.
  • Escalante-Domínguez AJ; Allergy and Immunology, Hospital General de Tijuana, Tijuana, Mexico.
  • Linares-Zapién FJ; Allergy and Immunology, Centro de Investigación, Diagnóstico y Tratamiento de Asma y Alergias, Toluca, Estado de México, Mexico.
  • Moreno-Gardea HL; Allergy and Immunology, Hospital Ángeles Chihuahua, Chihuahua, Mexico.
  • Ochoa-López G; Allergy and Immunology, Hospital Ángeles Ciudad Juárez, Chihuahua, Mexico.
  • Hernández-Mondragón LO; Allergy and Immunology, CRIT Michoacán, Morelia, Michoacán, Mexico.
  • Lozano-Sáenz JS; Allergy and Immunology, Hospital Ángeles Xalapa, Xalapa, Veracruz, Mexico.
  • Sacre-Hazouri JA; Allergy and Immunology, Universidad Veracruzana, Córdoba, Veracruz, Mexico.
  • Juan-Pineda Á; Allergy and Immunology, Private practice, Puerto Vallarta, Jalisco, Mexico.
  • Sánchez-Coronel MG; Allergy and Immunology, Benemérita Universidad Autónoma de Aguascalientes, Aguascalientes, Mexico.
  • Rodríguez-Pérez N; Allergy and Immunology, Benemérita Universidad Autónoma de Aguascalientes, Aguascalientes, Mexico.
  • Ambriz-Moreno MJ; Allergy and Immunology, Hospital General de Matamoros, Matamoros, Mexico.
BMJ Open Respir Res ; 7(1)2020 12.
Article em En | MEDLINE | ID: mdl-33268340
BACKGROUND: Global Asthma Network (GAN) was established in 2012 as a development to the International Study of Asthma and Allergies in Childhood to improve asthma care globally. OBJECTIVE: To survey asthma, allergic rhinitis and atopic dermatitis in primary and secondary school children and to investigate and evaluate its prevalence, severity, management and risk factors in Mexico. METHODS: GAN Phase I is a cross-sectional, multicentre survey carried out in 15 centres corresponding to 14 Mexican cities throughout 2016-2019 using the validated Spanish language version of the GAN Phase I questionnaires. The questionnaires were completed by parents of 6-7-year-old primary school pupils (school children) and by 13-14-year-old adolescents. RESULTS: A total of 35 780 school children and 41 399 adolescents participated. Wheezing ever prevalence was 26.2% (95% CI 25.8% to 26.7%) in school children and 23.9% (95% CI 23.4% to 24.3%) in adolescents. The corresponding frequencies for current wheeze were 10.2% (95% CI 9.9% to 10.5%) and 11.6% (95% CI 11.2% to 11.9%). In school children, the risk factors for current wheeze were rhinitis (OR 4.484; 95% CI 3.915% to 5.134%) and rash symptoms (OR 1.735; 95% CI 1.461% to 2.059%). For adolescents, rhinitis symptoms (OR 3.492; 95% CI 3.188% to 3.825%) and allergic rhinitis diagnosis (OR 2.144; 95% CI 1.787% to 2.572%) were the most significant. For both groups, there was a negative relation with centres' sea level altitude higher than 1500 m above mean sea level (p<0.005). CONCLUSIONS: The most important risk factors for asthma symptoms in both age groups were the presence of rhinitis and rash symptoms or diagnosis. On the other hand, sea level altitude higher than 1500 metres was a protective factor.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Asma / Altitude Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Adolescent / Child / Humans País/Região como assunto: Mexico Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Asma / Altitude Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Adolescent / Child / Humans País/Região como assunto: Mexico Idioma: En Ano de publicação: 2020 Tipo de documento: Article